In Vivo Tissue-tropism of Adeno-associated Viral Vectors

Overview

Journal Curr Opin Virol

Publisher Elsevier

Specialty Microbiology

Date 2016 Sep 7

PMID 27596608

Citations 190

Authors

Arun Srivastava

Affiliations

Soon will be listed here.

Abstract

In this review, a brief account of the historical perspective of the discovery of the first cellular receptor and co-receptor of the prototype adeno-associated virus serotype 2 (AAV2) will be presented. The Subsequent discovery of a number of AAV serotypes, and attempts to identify the cellular receptors and co-receptors for these serotype vectors has had significant implications in their use in human gene therapy. As additional AAV serotypes are discovered and isolated, a detailed understanding of their tropism is certainly likely to play a key role in all future studies, both basic science as well as clinical.

Citing Articles

Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates.

Liu M, Cook E, Dai Y, Ehlert E, du Plessis F, Lubelski J Mol Ther Methods Clin Dev. 2025; 33(1):101411.

PMID: 40027261 PMC: 11869850. DOI: 10.1016/j.omtm.2025.101411.

AAV-based vectors for human diseases modeling in laboratory animals.

Aliev T, Yudkin D Front Med (Lausanne). 2025; 11:1499605.

PMID: 40007819 PMC: 11859266. DOI: 10.3389/fmed.2024.1499605.

CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production.

ODriscoll E, Arora S, Lang J, Davidson B, Shalem O Mol Ther Methods Clin Dev. 2025; 33(1):101408.

PMID: 39980803 PMC: 11840188. DOI: 10.1016/j.omtm.2025.101408.

Gene therapy for genetic diseases: challenges and future directions.

Qie B, Tuo J, Chen F, Ding H, Lyu L MedComm (2020). 2025; 6(2):e70091.

PMID: 39949979 PMC: 11822459. DOI: 10.1002/mco2.70091.

mTOR downregulation promotes anti-inflammatory responses via the CCL3-CCR5 axis in hypoxic retinopathy.

Moon T, Kang I, Lee K, Kim J, Kim H, Han A Mol Ther Methods Clin Dev. 2025; 33(1):101404.

PMID: 39897639 PMC: 11787640. DOI: 10.1016/j.omtm.2024.101404.

References

Rutledge E, Halbert C, Russell D . Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol. 1998; 72(1):309-19. PMC: 109378. DOI: 10.1128/JVI.72.1.309-319.1998. View

Vite C, Passini M, Haskins M, Wolfe J . Adeno-associated virus vector-mediated transduction in the cat brain. Gene Ther. 2003; 10(22):1874-81. DOI: 10.1038/sj.gt.3302087. View

MacLaren R, Groppe M, Barnard A, Cottriall C, Tolmachova T, Seymour L . Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014; 383(9923):1129-37. PMC: 4171740. DOI: 10.1016/S0140-6736(13)62117-0. View

Feuer W, Schiffman J, Davis J, Porciatti V, Gonzalez P, Koilkonda R . Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. Ophthalmology. 2015; 123(3):558-70. PMC: 5287094. DOI: 10.1016/j.ophtha.2015.10.025. View

Gaudet D, Methot J, Dery S, Brisson D, Essiembre C, Tremblay G . Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 2012; 20(4):361-9. PMC: 4956470. DOI: 10.1038/gt.2012.43. View

Muramatsu S, Mizukami H, Young N, Brown K . Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology. 1996; 221(1):208-17. DOI: 10.1006/viro.1996.0367. View

Wang L, Bell P, Somanathan S, Wang Q, He Z, Yu H . Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther. 2015; 23(12):1877-87. PMC: 4700115. DOI: 10.1038/mt.2015.179. View

Corti M, Cleaver B, Clement N, Conlon T, Faris K, Wang G . Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning. Hum Gene Ther Clin Dev. 2015; 26(3):185-93. PMC: 4606909. DOI: 10.1089/humc.2015.068. View

Summerford C, Samulski R . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol. 1998; 72(2):1438-45. PMC: 124624. DOI: 10.1128/JVI.72.2.1438-1445.1998. View

10.

Schmidt M, Govindasamy L, Afione S, Kaludov N, Agbandje-Mckenna M, Chiorini J . Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J Virol. 2008; 82(17):8911-6. PMC: 2519687. DOI: 10.1128/JVI.00672-08. View

11.

Muzyczka N, Warrington Jr K . Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. Hum Gene Ther. 2005; 16(4):408-16. DOI: 10.1089/hum.2005.16.408. View

12.

Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, Rosenstein B . A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther. 1996; 7(9):1145-59. DOI: 10.1089/hum.1996.7.9-1145. View

13.

Summerford C, Bartlett J, Samulski R . AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med. 1999; 5(1):78-82. DOI: 10.1038/4768. View

14.

Rubenstein R, McVeigh U, Flotte T, Guggino W, Zeitlin P . CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector. Gene Ther. 1997; 4(5):384-92. DOI: 10.1038/sj.gt.3300417. View

15.

Mori S, Wang L, Takeuchi T, Kanda T . Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology. 2004; 330(2):375-83. DOI: 10.1016/j.virol.2004.10.012. View

16.

Ginn S, Alexander I, Edelstein M, Abedi M, Wixon J . Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med. 2013; 15(2):65-77. DOI: 10.1002/jgm.2698. View

17.

Byrne P, Collins S, Mah C, Smith B, Conlon T, Martin S . Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease. Hum Gene Ther Clin Dev. 2014; 25(3):134-63. DOI: 10.1089/humc.2014.2514. View

18.

Kashiwakura Y, Tamayose K, Iwabuchi K, Hirai Y, Shimada T, Matsumoto K . Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol. 2004; 79(1):609-14. PMC: 538679. DOI: 10.1128/JVI.79.1.609-614.2005. View

19.

Duan D, Yue Y, Yan Z, McCray Jr P, Engelhardt J . Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther. 1999; 9(18):2761-76. DOI: 10.1089/hum.1998.9.18-2761. View

20.

Vercauteren K, Hoffman B, Zolotukhin I, Keeler G, Xiao J, Basner-Tschakarjan E . Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. Mol Ther. 2016; 24(6):1042-1049. PMC: 4923326. DOI: 10.1038/mt.2016.61. View